QT Imaging Holdings Inc (QTI)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$2.23+3.24%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · QTI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -73.7% |
| Our one-year growth estimate | diamond | 95.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 168.7 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 29 industry peers
QTI — officer change
Dated 2026-08-31
CEO — Dr. Raluca Dinu: The filing discloses a routine equity compensation grant to the sitting CEO, not a change in management or departure.
Why it matters: The new code recognizes QT Imaging's service in the U.S. The key test is whether clinics can use it for payment and bring in more patients.
Supportive ifThe X579T Category III code takes effect on January 1, 2027, and QTI reports that clinics use it in payment claims.
Worry ifThe code's start date is delayed, or QTI reports no clinic use in payment claims after January 1, 2027.
Why it matters: A scanner at a leading medical center could add clinical evidence in women at high risk of breast cancer. The placement and study are still planned.
Supportive ifRambam confirms the scanner is in place. The planned study of women with hereditary risk has started.
Worry ifRambam cancels the scanner placement or study, or the scanner is not in place by the next company update.
Why it matters: Scanner shipments drove recent sales growth. More shipments would show that direct sales and distribution partners are reaching customers.
Supportive ifThe Q3 report shows more than 15 scanners shipped, above Q2's 15, with revenue above Q2's $7.4 million.
Worry ifThe Q3 report shows 15 or fewer scanners shipped, or revenue below Q2's $7.4 million.
Why it matters: Q2 gross margin fell from 50% a year earlier, while cash use and operating losses remain. A higher margin would show that sales are bringing in more after product costs.
Supportive ifThe Q3 report shows gross margin above 41%, the Q2 level.
Worry ifThe Q3 report shows gross margin at or below 41%.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$202 on $10,000 · ±2.0% | How much price usually moves either way. |
| Bad day | $640 loss on $10,000 · 6.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,181 loss on $10,000 · 71.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: QT Imaging reported $14.0 million in first-half revenue and kept its full-year goal near $39 million. Q3 results test whether sales can meet that goal.
Watch forOn November 9, Q3 revenue and new full-year guidance support about $39 million or more in 2026 revenue.
Also watch forQ3 revenue or a lower full-year outlook makes it hard to reach about $39 million in 2026.